| N | % | |
---|---|---|---|
Age at diagnosis, years | <50 | 68 | 55,7% |
>50 | 54 | 44,3% | |
Histology | Ductal | 105 | 86,8% |
Lobular | 12 | 9,9% | |
Other | 4 | 3,3% | |
Tumour grade | 1 | 9 | 7,6% |
2 | 69 | 58,5% | |
3 | 40 | 33,9% | |
Lymph node status | none | 35 | 30,2% |
1–3 positive | 35 | 30,2% | |
>3 positive | 46 | 39,7% | |
Neoadjuvant chemotherapy | no | 100 | 82,6% |
yes | 21 | 17,4% | |
Adjuvant therapy | none | 23 | 19,0% |
only CT | 39 | 32,2% | |
only HT | 15 | 12,4% | |
CTÂ +Â HT | 44 | 36,4% |